E.I. Du Pont De Nemours and Company (DD) 67.56

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
E.I. Du Pont De Nemours and Company (DD) 67.56 $DD

Agricultural Chemicals Industry's Stocks Get Research Review
ACCESSWIRE - Fri Jun 10, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 10, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Agricultural Chemicals industry. Companies recently under review include E. I. du Pont de Nemours, Intrepid Potash, Syngenta, and Ceres. Register with us now for your free membership and see our complete reports on these equities at:
SYT: 81.17 (-0.39), CERE: 0.25 (-0.05), DD: 67.56 (-0.34), IPI: 1.27 (-0.08)


Dow and DuPont set date for shareholder votes on merger
AP - Fri Jun 10, 8:05AM CDT
NEW YORK (AP) — DuPont and Dow Chemical said Friday that they will hold separate shareholder meetings next month to vote on their merger.
DD: 67.56 (-0.34), DOW: 53.38 (-0.21)

Dow and DuPont Announce DowDuPont Inc. Form S-4 Registration Statement Declared Effective by SEC
PR Newswire - Fri Jun 10, 6:30AM CDT
DuPont (NYSE: DD) and The Dow Chemical Company (NYSE: DOW) today announced that the registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission ("SEC" by DowDuPont Inc. ("DowDuPont" on March 1, 2016, as amended, was declared effective on June 9, 2016. The registration statement was filed in connection with the proposed merger of equals of Dow and DuPont and includes a joint proxy statement of Dow and DuPont and a prospectus of DowDuPont.
DD: 67.56 (-0.34), DOW: 53.38 (-0.21)

Zacks Investment Ideas feature highlights: Wal-Mart, DuPont, Home Depot, United Health and Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:30AM CDT
Zacks Investment Ideas feature highlights: Wal-Mart, DuPont, Home Depot, United Health and Johnson & Johnson
JNJ: 117.01 (+0.01), HD: 128.83 (-0.47), UNH: 139.24 (-1.44), DD: 67.56 (-0.34), WMT: 71.14 (+0.05)

DuPont, Arcadia Jointly Develop ARA Oil from Safflower Plants
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 4:57PM CDT
DuPont's (DD) unit DuPont Pioneer and Arcadia Biosciences, Inc. announced that they have successfully completed a field-trial validation of safflower plants that produce high levels of arachidonic acid (ARA) oil for global consumer markets.
IOSP: 49.33 (-0.19), DD: 67.56 (-0.34), IPHS: 40.81 (+0.38)

5 Dow Stocks to Buy This Summer
Jeremy Mullin - Zacks Investment Research - Thu Jun 02, 1:08PM CDT
5 Dow Stocks to Buy This Summer
JNJ: 117.01 (+0.01), HD: 128.83 (-0.47), UNH: 139.24 (-1.44), DD: 67.56 (-0.34), WMT: 71.14 (+0.05)

Stock Market News for June 01, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 9:10AM CDT
Benchmarks ended mostly in the red on Tuesday following a cautious stance among investors ahead of the release of major economic reports this week
KO: 45.99 (+0.23), MON: 109.20 (-0.79), EA: 75.28 (-0.97), PFE: 35.29 (-0.02), SYY: 48.78 (-0.22), STZ: 153.40 (-0.70), XOM: 89.98 (-0.69), PEP: 103.31 (-0.35), NVDA: 46.20 (-1.18), DD: 67.56 (-0.34), PG: 83.20 (+0.03), CVX: 101.98 (-0.83), DOW: 53.38 (-0.21), PPG: 109.24 (-1.19), ECL: 120.25 (-0.54)

Arcadia Biosciences and DuPont Pioneer Achieve Milestone in the Development of High-Value Specialty Oil
BusinessWire - Wed Jun 01, 7:00AM CDT
Arcadia Biosciences, Inc. (Nasdaq: RKDA) and DuPont Pioneer (NYSE: DD) today announced the successful field-trial validation of safflower plants that produce high levels of arachidonic acid (ARA) oil, a high-value, specialty nutritional oil for global consumer markets. The achievement of this key milestone represents a significant step in the collaboration between Arcadia and DuPont Pioneer to develop a new plant-based and cost-effective source of oil with high levels of ARA.
RKDA: 1.69 (+0.14), DD: 67.56 (-0.34)

Watch for EI Du Pont de Nemours to Potentially Rebound After Falling 1.37% Yesterday
Comtex SmarTrend(R) - Tue May 31, 2:39PM CDT
EI Du Pont de Nemours (NYSED) traded in a range yesterday that spanned from a low of $66.18 to a high of $67.49. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $66.65 on volume of 867,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DD: 67.56 (-0.34)

Look for Shares of EI Du Pont de Nemours to Potentially Rebound after Yesterday's 1.37% Sell Off
Comtex SmarTrend(R) - Tue May 31, 2:38PM CDT
EI Du Pont de Nemours (NYSED) traded in a range yesterday that spanned from a low of $66.18 to a high of $67.49. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $66.65 on volume of 867,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DD: 67.56 (-0.34)

DuPont Features Latest High-Power Solar Panel at SNEC 2016
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:59AM CDT
DuPont's (DD) Photovoltaic Solutions business featured the latest solar panel from Xi'an Solar Power Co, Ltd., a unit of State Power Investment Corporation (SPIC), at SNEC 2016.
IOSP: 49.33 (-0.19), DD: 67.56 (-0.34), IPHS: 40.81 (+0.38)

Stock Market News for May 27, 2016
Zacks Equity Research - Zacks Investment Research - Fri May 27, 9:10AM CDT
Benchmarks closed mixed on Thursday as investors took a cautious stance ahead of Fed Chair Janet Yellen’s comments expected today
MON: 109.20 (-0.79), PCG: 63.02 (+0.04), DUK: 81.24 (-0.02), FCX: 10.36 (-0.54), C: 43.90 (-1.11), XOM: 89.98 (-0.69), BAC: 13.83 (-0.36), MS: 25.54 (-0.54), AEP: 66.85 (-0.11), DLTR: 91.34 (-0.63), LYB: 80.47 (+0.55), GS: 149.89 (-3.28), JPM: 63.84 (-0.91), CF: 29.23 (-0.56), DD: 67.56 (-0.34), CVX: 101.98 (-0.83), DOW: 53.38 (-0.21)

SmarTrend Watching for Potential Pullback in Shares of EI Du Pont de Nemours After 1.13% Gain
Comtex SmarTrend(R) - Tue May 24, 2:09PM CDT
EI Du Pont de Nemours (NYSED) traded in a range yesterday that spanned from a low of $67.00 to a high of $67.78. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $67.15 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DD: 67.56 (-0.34)

After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 24, 2:07PM CDT
EI Du Pont de Nemours (NYSED) traded in a range yesterday that spanned from a low of $67.00 to a high of $67.78. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $67.15 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DD: 67.56 (-0.34)

4 Dow Members Bucking the Negative Trend
Zacks Equity Research - Zacks Investment Research - Tue May 24, 8:58AM CDT
These four Dow components outperformed the index over the past three-month time frame.
JNJ: 117.01 (+0.01), UNH: 139.24 (-1.44), PFE: 35.29 (-0.02), XOM: 89.98 (-0.69), DD: 67.56 (-0.34), CVX: 101.98 (-0.83), AAPL: 98.83 (-0.82)

ETFs to Watch on Monsanto Buyout Offer
Sweta Killa - Zacks Investment Research - Tue May 24, 8:46AM CDT
The German chemical giant made all-cash bid to acquire Monsanto for $62 billion, including debt, putting these ETFs on spotlight.
XLB: 47.74 (-0.36), SYT: 81.17 (-0.39), MON: 109.20 (-0.79), MOO: 49.05 (-0.78), VEGI: 24.62 (+0.11), IYM: 78.60 (-0.41), DD: 67.56 (-0.34), DOW: 53.38 (-0.21)

Dow and DuPont Announce Senior Leadership Appointments for DowDuPont
PR Newswire - Mon May 23, 4:00PM CDT
DuPont (NYSE: DD) and The Dow Chemical Company (NYSE: DOW) today announced senior leadership appointments for DowDuPont Inc. ("DowDuPont", following the consummation of the proposed merger of equals.
DD: 67.56 (-0.34), DOW: 53.38 (-0.21)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 2

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 1

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 3

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 2

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 1

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 2

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 3

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming $100 Into Significant Wealth with MANH Stock

Updated Category News Views 175

Unlocking Wealth: The Manhattan Associates Investment Narrative Let’s dive into a real financial gem that’s often overshadowed by bigger names—Manhattan Associates (NASDAQ: MANH). This company isn’t just another name in the tech universe; it’s been killing it in the stock market arena with an annualized growth rate that clocks in at 18.87%. If you crunch those...

Continue Reading
Investors Alert: Class Action Opportunities with Law Offices

Updated Category News Views 176

Class Action Lawsuits Overview Investors are being reminded about important class action lawsuits related to several publicly-traded companies. These class actions provide shareholders an opportunity to seek justice for alleged securities fraud. The Law Offices of Howard G. Smith has initiated these lawsuits, urging affected investors to explore their legal options....

Continue Reading
Brink's Announces Earnings Call for Upcoming Financial Results

Updated Category News Views 136

Brink's Company Earnings Call Announcement RICHMOND, Va. — The Brink’s Company (NYSE: BCO), a premier global provider specializing in cash and valuables management, digital retail solutions, and ATM managed services, has announced that it will conduct a conference call to discuss the financial results from the second-quarter of the year. This event is slated for...

Continue Reading
Significant New Share Offering by DSV A/S Bolsters Financial Growth

Updated Category News Views 203

DSV A/S finalized a hefty equity offering that raised DKK 37.3 billion—about EUR 5 billion—in early 2024. They dropped a massive 26,444,523 new shares on the market to shore up their finances for the acquisition of Schenker AG from Deutsche Bahn. Traders were quick to gauge what this meant: a serious boost in their logistics game. Equity Offering Details: What's...

Continue Reading
AmacaThera Partners with Pacira BioSciences in Major Deal

Updated Category News Views 130

AmacaThera Develops Game-Changing Partnership with Pacira BioSciences AmacaThera has recently entered into a significant exclusive global licensing agreement with Pacira BioSciences, marking a pivotal moment for the innovative drug delivery company. This partnership is centered around AMT-143, AmacaThera's advanced long-acting non-opioid anesthetic designed for...

Continue Reading